Home > About us

Autorizzo al trattamento dei miei dati personali
ai sensi del D.L. 30 giugno 2003 n. 196
Edit email address
Invalid email
Your request has been sent successfully
Authorize the processing of personal data

We are an international group based in Parma, research-oriented, with over 85 years of experience, present in 30 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).

 

Since 2019 we have been the largest pharmaceutical group in the world certified B Corp, while, in 2018, we changed our legal status to a Benefit Company, realizing the desire to measure our impact on society and the environment, combining the need to generate value for the business to acting as a positive force for the community in which we live.

 

With a consolidated turnover of 2 billion and 229 million euros we are among the top 50 pharmaceutical companies in the world. The Group's Research and Development is based in Parma and integrates with six other major research centers in France, the United States, Canada, China, the United Kingdom and Sweden, to promote its preclinical, clinical and regulatory programs. Our production activity, on the other hand, takes place in three plants located in Parma (Italy), Blois (France) and Santana de Parnaiba (Brazil).
 
Our Headquarters

 

We export to more than 100 countries with a direct presence in 30.

 

More than 6,389 Chiesi people around the world, of which around 944 are dedicated to research and development.

  • Italy

  • Brazil

  • China

  • Germany

  • Greece

  • Italy

  • Mexico

  • Pakistan

  • United Kindom

  • USA

  • Belgium

  • Austria